Elevated levels of STAT3 is observed in tumor‐infiltrating immune cells and plays negative regulatory effects on neutrophils, natural killer (NK) cells, effector T cells, and DCs, indicating that STAT3 activation in immune cells likely leads to the down‐modulation of antitumor immunity.75 The gene discussed is STAT3; the disease is neoplasm.